was read the article
array:23 [ "pii" => "S1988885615000073" "issn" => "19888856" "doi" => "10.1016/j.recote.2015.01.005" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "aid" => "527" "copyright" => "SECOT" "copyrightAnyo" => "2014" "documento" => "article" "subdocumento" => "fla" "cita" => "Rev Esp Cir Ortop Traumatol. 2015;59:104-11" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 198 "formatos" => array:2 [ "HTML" => 103 "PDF" => 95 ] ] "Traduccion" => array:1 [ "es" => array:18 [ "pii" => "S1888441514001702" "issn" => "18884415" "doi" => "10.1016/j.recot.2014.07.010" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "aid" => "527" "copyright" => "SECOT" "documento" => "article" "subdocumento" => "fla" "cita" => "Rev Esp Cir Ortop Traumatol. 2015;59:104-11" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 475 "formatos" => array:3 [ "EPUB" => 11 "HTML" => 306 "PDF" => 158 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "Antiagregación en pacientes con fractura subcapital desplazada de fémur tratados con prótesis parcial cementada. Estudio de complicaciones y mortalidad" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "104" "paginaFinal" => "111" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Anti-platelet drugs in patients with femoral neck fractures undergoing cemented hip hemiarthroplasty surgery. A study of complications and mortality" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1140 "Ancho" => 1617 "Tamanyo" => 85262 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Mortalidad acumulada en los 3 grupos.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Agudo Quiles, J. Sanz-Reig, R. Alcalá-Santaella Oria de Rueca" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Agudo Quiles" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Sanz-Reig" ] 2 => array:2 [ "nombre" => "R." "apellidos" => "Alcalá-Santaella Oria de Rueca" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1988885615000073" "doi" => "10.1016/j.recote.2015.01.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1988885615000073?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1888441514001702?idApp=UINPBA00004N" "url" => "/18884415/0000005900000002/v2_201502230216/S1888441514001702/v2_201502230216/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S1988885615000085" "issn" => "19888856" "doi" => "10.1016/j.recote.2014.09.011" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "aid" => "533" "copyright" => "SECOT" "documento" => "article" "subdocumento" => "fla" "cita" => "Rev Esp Cir Ortop Traumatol. 2015;59:112-21" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 274 "formatos" => array:2 [ "HTML" => 160 "PDF" => 114 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Factors associated with the failure of arthroscopic surgery treatment in patients with femoroacetabular impingement: A cohort study" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "112" "paginaFinal" => "121" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Factores asociados al fracaso terapéutico de la cirugía artroscópica en pacientes con choque femoroacetabular: un estudio de cohorte" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1934 "Ancho" => 1199 "Tamanyo" => 121002 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Algorithm showing the process of patient inclusion.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "D. Martínez, J. Gómez-Hoyos, W. Márquez, J. Gallo" "autores" => array:4 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Martínez" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Gómez-Hoyos" ] 2 => array:2 [ "nombre" => "W." "apellidos" => "Márquez" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Gallo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1888441514001921" "doi" => "10.1016/j.recot.2014.09.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1888441514001921?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1988885615000085?idApp=UINPBA00004N" "url" => "/19888856/0000005900000002/v2_201502210342/S1988885615000085/v2_201502210342/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S1988885615000061" "issn" => "19888856" "doi" => "10.1016/j.recote.2015.01.004" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "aid" => "526" "copyright" => "SECOT" "documento" => "article" "subdocumento" => "fla" "cita" => "Rev Esp Cir Ortop Traumatol. 2015;59:97-103" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 196 "formatos" => array:2 [ "HTML" => 70 "PDF" => 126 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Distal radius fractures: Should we use supplemental bone grafts or substitutes in cases of severe osteoporotic or comminution?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "97" "paginaFinal" => "103" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Fracturas de radio distal: ¿es necesario el aporte de injerto o sustitutivo óseo en los casos con osteoporosis o conminución severa?" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1437 "Ancho" => 979 "Tamanyo" => 116416 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Radiograph with the wrist in lateral projection. Type C3 distal radius fracture according to the AO classification. Type C3 distal radius fracture according to the AO classification synthesized with a volar LCP plate. Radiographic control 1 year after the surgery. Mirror image of the healthy contralateral wrist.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Garcés-Zarzalejo, M.R. Sánchez-Crespo, F. Peñas-Díaz, H. Ayala-Gutiérrez, J.R. Sanz Giménez-Rico, A. Alfonso-Fernández, V. Burgos-Palacios, F. del Canto-Álvarez" "autores" => array:8 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Garcés-Zarzalejo" ] 1 => array:2 [ "nombre" => "M.R." "apellidos" => "Sánchez-Crespo" ] 2 => array:2 [ "nombre" => "F." "apellidos" => "Peñas-Díaz" ] 3 => array:2 [ "nombre" => "H." "apellidos" => "Ayala-Gutiérrez" ] 4 => array:2 [ "nombre" => "J.R." "apellidos" => "Sanz Giménez-Rico" ] 5 => array:2 [ "nombre" => "A." "apellidos" => "Alfonso-Fernández" ] 6 => array:2 [ "nombre" => "V." "apellidos" => "Burgos-Palacios" ] 7 => array:2 [ "nombre" => "F." "apellidos" => "del Canto-Álvarez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1988885615000061?idApp=UINPBA00004N" "url" => "/19888856/0000005900000002/v2_201502210342/S1988885615000061/v2_201502210342/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Anti-platelet drugs in patients with femoral neck fractures undergoing cemented hip hemiarthroplasty surgery. A study of complications and mortality" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "104" "paginaFinal" => "111" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Agudo Quiles, J. Sanz-Reig, R. Alcalá-Santaella Oria de Rueca" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Agudo Quiles" ] 1 => array:4 [ "nombre" => "J." "apellidos" => "Sanz-Reig" "email" => array:1 [ 0 => "javisanz@coma.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 2 => array:2 [ "nombre" => "R." "apellidos" => "Alcalá-Santaella Oria de Rueca" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Cirugía Ortopédica, Hospital Universitario San Joan d’Alacant, Sant Joan d’Alacant, Alicante, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Antiagregación en pacientes con fractura subcapital desplazada de fémur tratados con prótesis parcial cementada. Estudio de complicaciones y mortalidad" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1140 "Ancho" => 1617 "Tamanyo" => 88032 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Cumulative mortality in the 3 groups.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The association of hip fractures with anti-platelet (or anti-aggregant) drugs is increasingly common among patients suffering hip fractures, particularly elderly patients, and this conditions their perioperative management due to the theoretical risks associated to surgical bleeding.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Anti-aggregant drugs are indicated as prophylaxis or treatment of arterial thrombotic processes, with a variable response due to patient idiosyncrasies, non-compliance with therapeutic patterns and drug interactions, as these subjects are often polymedicated.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">1</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">There is a general consensus that surgical treatment is the best option for hip fractures, as it reduces morbidity and mortality.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">2</span></a> Delaying surgery in patients with anti-aggregants aims to prevent the onset of anesthetic and hemorrhagic complications, as well as the need for transfusions. On the other hand, delaying the intervention could increase morbidity and mortality and delay functional recovery.</p><p id="par0020" class="elsevierStylePara elsevierViewall">In 2007, the Spanish Society of Traumatology and Orthopedic Surgery (SECOT) published the Guide for Elderly Hip Fracture Patients, which indicated that the optimal moment for surgery depended on the general condition of each patient, as well as their comorbidities and concomitant treatments. In addition, the delay was also influenced by intrinsic factors of the healthcare system or working routine of each hospital. The association of both groups of factors led to surgical delays of over 24<span class="elsevierStyleHsp" style=""></span>h becoming common at our hospitals. Regarding the management of acetylsalicylic acid (ASA) among patients with hip fractures, the Guide stated that although the decision about when to carry out the surgery in this kind of patients should contemplate the risks and benefits in each specific case, delaying the operation was not justified and patients should be intervened as soon as possible.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">3</span></a> Nevertheless, it was not until 2011 that the Spanish Society of Anesthesiology, Reanimation and Pain Therapy (SEDAR) published the Clinical Practice Guideline for the Perioperative Management of Anti-platelet Drugs in Non-Cardiac Surgery, which indicated that the preoperative decision to interrupt or continue treatment with anti-platelet agents should always be based on a detailed and individualized assessment of each patient which evaluated the probable increase in thrombotic risk in case of interruption versus the hypothetical increase of the hemorrhagic risk derived from its maintenance. The Guide recommended suspending ASA between 2 and 5 days and clopidogrel between 3 and 7 days for the perioperative management of non-cardiac surgery.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">4</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The difference in criteria between anesthesiologists and traumatologists at our center led us to consider the hypothesis that there was a greater incidence of complications and mortality 1 year after the surgery comparing between patients with and without anti-platelet therapy who suffered displaced subcapital fractures of the femur treated through cemented hip hemiarthroplasty.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Material and method</span><p id="par0030" class="elsevierStylePara elsevierViewall">Between January 2008 and December 2010, our database of hip fractures registered a total of 339 proximal femoral fractures, of which 152 (44.8%) were subcapital femoral fractures and, out of these, 140 (41.2%) were displaced. Of the 140 patients with displaced subcapital femoral fractures, 83 (59.3%) were not taking any anticoagulant or anti-aggregant medication at the time of hospital admission, 50 (35.7%) patients were taking anti-aggregant medication and 7 (5%) patients were taking anticoagulant medication. Patients with pathological fractures, multiple trauma, coagulopathies, thrombocytopenia (platelet counts under 150<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>109/l), following anticoagulant treatment with dicoumarins, and those with absolute contraindication for interruption of the anti-aggregant treatment were all excluded, as they did not correspond to the objective of the study. There were no follow-up losses.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The demographic data of each patient were recorded during hospital admission, as were the type of fracture, type of intervention, surgical delay, days of hospital admission and associated comorbidities. Preanesthetic risk was assessed through the ASA (American Society of Anesthesiologists) scale.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">5</span></a> In order to determine the associated comorbidities we considered those with a greater influence on the prognosis of the fracture, such as arterial hypertension (AHT), cardiopathy, pulmonary disease, nephropathy, cerebrovascular accident (CVA), diabetes, rheumatism, Parkinson's and dementia.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">3</span></a> The assessment of cognitive function was carried out through the mini-mental test with a maximum score of 10, considering a score of 6 or lower as suggestive of dementia.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">6</span></a> At the time of admission, patients were examined by the Internal Medicine and Emergency Service, which focused on their associated medical pathology and indicated the removal of anti-aggregant treatment (ASA 300<span class="elsevierStyleHsp" style=""></span>mg in 19 patients, ASA 100<span class="elsevierStyleHsp" style=""></span>mg in 18 patients and clopidogrel in 13 patients) regardless of the type of antiaggregation and dosage, initiating antithrombotic prophylaxis with low molecular weight heparin (enoxaparin 40<span class="elsevierStyleHsp" style=""></span>U subcutaneously every 24<span class="elsevierStyleHsp" style=""></span>h). Surgical delay was established by the Anesthesiology and Reanimation Service based on the type of anti-aggregant treatment of each patient. The associated comorbidities were stabilized during this period if necessary, but patients were not intervened until they had completed the period of antiaggregation removal indicated by the Anesthesiology and Reanimation Service.</p><p id="par0040" class="elsevierStylePara elsevierViewall">All patients were intervened under spinal anesthesia using a cemented modular partial prosthesis (Polarstem, Smith & Nephew, UK), through a posterior approach with the usual technique. Antibiotic prophylaxis (cefazolin, 2<span class="elsevierStyleHsp" style=""></span>g previously and 1<span class="elsevierStyleHsp" style=""></span>g every 8<span class="elsevierStyleHsp" style=""></span>h, 3 doses, postoperative intravenous; in allergic subjects, vancomycin 1<span class="elsevierStyleHsp" style=""></span>g previously and 1<span class="elsevierStyleHsp" style=""></span>g in a single postoperative intravenous dose) and antithrombotic prophylaxis (enoxaparin 40<span class="elsevierStyleHsp" style=""></span>U subcutaneously every 24<span class="elsevierStyleHsp" style=""></span>h for 1 month after intervention) were identical in all cases. Surgical drainage was used systematically in all cases and removed after 48<span class="elsevierStyleHsp" style=""></span>h, and the analysis was requested on the same day as the surgery. Blood transfusion was indicated if postoperative Hb was under 8<span class="elsevierStyleHsp" style=""></span>g/dl. Patients were moved to a chair on the first day after the intervention and started to walk using a frame on the second day, if possible. The Internal Medicine Service was consulted before indicating reintroduction of anti-aggregant therapy after the surgery.</p><p id="par0045" class="elsevierStylePara elsevierViewall">In order to record the complications and mortality of the process, patients were reviewed at the outpatient clinic 1, 3, 6 and 12 months after the surgery. Patients were contacted by telephone if they did not attend the review.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The influence of hip fractures on mortality was established until the first year after the trauma, so this follow-up period was indicated as end point, unless death occurred sooner.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">7</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Patients with the same type of fracture and surgical treatment, conducted during the same period of time, and who were not taking anti-aggregant medication at the time of hospital admission were considered as control group in terms of comparing mortality and complications between patients who were on anti-aggregants and those who were not. The type of prosthesis, surgical procedure, postoperative management and revisions in outpatient consultation were identical to those of the group of anti-platelet patients.</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Statistical analysis</span><p id="par0060" class="elsevierStylePara elsevierViewall">The statistical analysis was conducted using the statistics software package SPSS. We carried out univariate studies, using the Mantel–Haenszel non-parametric or the chi squared test with Yates correction, as applicable, for qualitative variables, as well as the Mann–Whitney non-parametric or Wilcoxon sign test, or the paired or independent Student <span class="elsevierStyleItalic">t</span>-test, as applicable, for continuous variables. In the case of univariate tests with significant relationship, we used as independent covariates in the logistic regression analysis with respect to mortality. We considered as significant a value of <span class="elsevierStyleItalic">P</span> equal to or lower than .05.</p></span></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Results</span><p id="par0065" class="elsevierStylePara elsevierViewall">The sample of patients with anti-aggregant treatment comprised 50 subjects with a mean age of 84.1 years (range: 68–96 years; SD: 6.6 years). The gender distribution was 37 females (74%) and 13 males (26%). The right hip was affected in 26 patients (52%), and the left in 24 (48%).</p><p id="par0070" class="elsevierStylePara elsevierViewall">Regarding associated comorbidities, 39 patients (78%) were diagnosed with arterial hypertension (AHT), 15 (30%) with cardiopathy, 12 (24%) with diabetes, 12 (24%) with dementia, 10 (20%) with CVA, 7 (14%) with pulmonary disease and 2 (4%) with Parkinson's. When grouped, 21 patients (42%) presented 1 or 2 associated comorbidities, and 29 patients (58%) suffered 3 or more associated comorbidities. According to the preanesthetic ASA classification, there were 10 patients (20%) with grade II, 35 (50%) with grade III and 5 (10%) with grade IV. The score in the mini-mental test was 6 points or less (indicative of dementia) in 12 patients (24%).</p><p id="par0075" class="elsevierStylePara elsevierViewall">Comparison of the preoperative data from both groups (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>) showed a significant difference regarding age—which was higher in the group of patients treated with anti-platelet drugs—and the diagnosis of AHT, heart pathology and CVA, with a higher presence in the group of anti-platelet patients. The number of comorbidities and ASA grade III/IV cases was also higher in the group of anti-platelet patients, with a significant difference. The mean value of preoperative Hb was of 12.9<span class="elsevierStyleHsp" style=""></span>g/dl (range: 8.5–17.2; SD: 1.7) among anti-platelet patients, and of 13.0<span class="elsevierStyleHsp" style=""></span>g/dl (range: 9.4–17.6; SD: 1.6) among patients not treated with anti-aggregants, with no significant difference (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.87).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0080" class="elsevierStylePara elsevierViewall">The mean surgical delay was of 4.2 days in the group of patients treated with anti-platelet drugs and of 3.4 days in the group of those who were not, with no significant differences (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.08). The duration of hospital admission was similar in both groups, with a mean 9.7 days in the group of antiaggregation patients compared to 9.3 days in the group of non antiaggregation patients (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.61). The mean value of postoperative hemoglobin was 10.7<span class="elsevierStyleHsp" style=""></span>g/dl (range: 6.5–14.1; SD: 1.6) in the group of antiaggregation patients and 10.8<span class="elsevierStyleHsp" style=""></span>g/dl (range: 6.8–14; SD: 1.5) in the group without anti-platelet therapy; very similar in both groups (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.92). A total of 7 patients (14%) in the antiaggregation group required a blood transfusion in the immediate postoperative period, compared to 21 patients (25%) in the non anti-aggregation group, with no significant differences (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.09). The mean number of packed red blood cells transfused was 2.2 (range: 2–4; SD: 0.7) in the group of patients with anti-platelet treatment and of 2.5 (range: 2–5; SD: 0.9) in the group of patients without anti-platelet treatment, with no significant differences (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.51).</p><p id="par0085" class="elsevierStylePara elsevierViewall">There were no intraoperative complications or need for revision surgery 1 year after the intervention in any of the 2 groups. Two patients (4%) in the anti-platelet group presented superficial infection, compared to 4 patients (4.8%) in the group without anti-platelets, with no significant differences (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.59). All cases were resolved through periodic cures and antibiotic therapy. There were medical complications in 9 (10.8%) patients without anti-platelet treatment and in 9 (18%) anti-platelet patients (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.18). The ASA classification grade was not associated with a greater incidence of surgical (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.25) and medical (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.41) complications.</p><p id="par0090" class="elsevierStylePara elsevierViewall">At 12 months after the intervention, the cumulative mortality taking both groups into account was 20.3% (27 patients). None of the patients died during hospital admission. There was a significant difference (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.02) between mortality in the group of antiaggregation patients (15 patients, 30%) and that in the group of non anti-aggregation patients (12 patients, 14.4%) (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Simple regression analysis identified the following risk factors for mortality at 1 year: age (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.01), antiaggregation treatment (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.03), ASA grade (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.03) and the number of associated comorbidities (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.02). Multiple regression analysis identified an association of the following factors with mortality at 1 year: (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.01), antiaggregation treatment (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.02), ASA grade (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.02) and the number of associated comorbidities (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.009). The odds ratio for mortality among anti-aggregation patients was 1.6 (95% CI: 1.0–2.5), compared to 0.6 (95% CI: 0.4–1.0) in the group of non anti-aggregation patients.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0095" class="elsevierStylePara elsevierViewall">In the group of patients with anti-platelet agents, the mean age of deceased cases was 87.8 years, significantly higher (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.007) than in the case of survivors, with a mean age of 82.5 years. The mean number of associated comorbidities was higher among deceased cases (4.0 versus 2.8), with a significant difference (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.03). The number of patients with ASA grade III/IV was also higher among deceased cases (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.05). There were no differences in gender (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.13), surgical delay (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.75), presence of 3 or more associated comorbidities (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.17) and presence of dementia (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.21).</p><p id="par0100" class="elsevierStylePara elsevierViewall">Out of the 50 patients taking anti-platelet agents, 37 were treated with ASA and 13 with clopidogrel. The general data of both groups is shown in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>. The only differences between both groups were found in surgical delay, hospital stay and postoperative complications. At 12 months after the surgery, 6 patients (46.1%) following anti-aggregation treatment with clopidogrel had died, compared to 9 patients (24.3%) following anti-aggregation treatment with ASA (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Discussion</span><p id="par0105" class="elsevierStylePara elsevierViewall">The limitations of our study include being a retrospective study and the scarce numbers of patients following antiaggregation treatment with clopidogrel and suffering displaced subcapital femoral fracture. On the other hand, we believe that the advantages include not having any losses during follow-up and a uniform sample as regards the type of fracture, surgical treatment, postoperative management and monitoring.</p><p id="par0110" class="elsevierStylePara elsevierViewall">In our study, mortality at 12 months was higher among patients with anti-platelets (30%) than among those not following antiaggregation treatment (14.4%). Furthermore, in the anti-platelet group, mortality was higher among those patients treated with clopidogrel (46.1%) than those treated with ASA (24.3%). Maheshwari et al.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">8</span></a> reported mortality at 12 months among 26% of 31 patients suffering proximal femoral fracture following antiaggregation treatment with clopidogrel, although the series was not uniform regarding the type of fracture and surgical treatment. Mas-Atance et al.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">9</span></a> indicated a mortality of 23.8% at 12 months in 105 patients with proximal femoral fracture who were not following anti-aggregation treatment versus 32.4% in 34 anti-platelet patients intervened before 48<span class="elsevierStyleHsp" style=""></span>h, as well as 47.2% in 36 anti-platelet patients intervened after the fifth day of admission. However, like the previous work, this series was not uniform regarding the type of fracture and surgical treatment.</p><p id="par0115" class="elsevierStylePara elsevierViewall">The risk factors for mortality described in the literature are varied, although not uniformly. In a metaanalysis, Hu et al.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">10</span></a> indicated that advanced age, male gender, place of residence, limited capacity for walking prior to the fracture, dependence for daily life activities, ASA grade, multiple associated comorbidities, dementia, diabetes, cancer and heart pathology were all predictive factors of mortality among patients with hip fracture, although well-designed studies would be required to specify this evidence. In another study, Navarrete et al.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">11</span></a> identified gender and prior general condition as statistically significant risk variables for mortality at 1 year among patients suffering hip fracture. In a series of patients aged over 65 years and suffering cervical fractures treated with partial hip prostheses, Lim et al.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">12</span></a> found an annual global mortality of 11%, although significantly associated to age. Mas-Atance et al.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">9</span></a> reported an association between the Barthel index prior to the fracture and the number of transfusions and mortality at 12 months among patients with anti-platelets. Maheshwari et al.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">8</span></a> associated surgical delay as the only predictive factor of mortality at 1 year among patients following anti-aggregation treatment with clopidogrel. In our study, mortality at 1 year was significantly related to anti-aggregation, age, ASA grade and the number of associated comorbidities, in both the univariate and multivariate regression studies.</p><p id="par0120" class="elsevierStylePara elsevierViewall">Surgical delay is a controversial factor in the treatment of hip fractures. In general, clinical guides<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">3,13</span></a> recommend carrying out the intervention within 24–36<span class="elsevierStyleHsp" style=""></span>h, whenever the condition of the patient allows it, in order to reduce morbidity and mortality, as long as this haste to perform the intervention does not detract from optimizing medical aspects. The published works show varying results. After reviewing 52 published studies, Khan et al.<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">14</span></a> concluded that early surgery (before 48<span class="elsevierStyleHsp" style=""></span>h) was associated to lower mortality with no increase of postoperative complications. Moran et al.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">15</span></a> indicated a higher mortality at 90 days and at 1 year among 2660 patients intervened for hip fractures after the fourth day of hospital admission compared to patients intervened within the first 4 days. Lefaivre et al.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">16</span></a> did not report this association, although they did agree that surgical delay was associated to a higher number of postoperative complications. Likewise, in a study reviewing 18,817 hip fractures, Holt et al.<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">17</span></a> did not find an association between mortality and surgical delay. Among patients treated with anti-platelet drugs, Mas-Atance et al.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">9</span></a> reported that interventions conducted before 48<span class="elsevierStyleHsp" style=""></span>h of hospital admission showed an increase of intraoperative bleeding, with no relevant clinical significance, whereas delay beyond the fifth day did not improve the clinical and analytical results and showed a trend toward increasing mortality. Maheshwari et al.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">8</span></a> found that surgical delay was the only predictive factor of mortality at 1 year of surgery in patients following antiaggregation treatment with clopidogrel. In our series, surgical delay was greater among patients with antiaggregation treatment, with no influence on mortality at 12 months or on a higher incidence of postoperative complications.</p><p id="par0125" class="elsevierStylePara elsevierViewall">ASA grade was an adequate test of significant risk of death following hip fracture.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">18</span></a> In our study, 80% of patients with anti-platelets were ASA grade III–IV, compared to 27.7% of non anti-platelet patients. Medical stabilization of patients prior to surgery led to better conditions when facing an intervention, as well as a reduction of mortality during hospital admission and the immediate postoperative period. None of the patients in our series died during hospital admission and mortality at 3 months was similar between patients following anti-platelet treatment and those who were not. There was an association between ASA grade and mortality at 12 months in anti-platelet patients, as also reported by Navarrete et al.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">11</span></a> and by Lim et al.,<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">12</span></a> although their patients were intervened in the first 48<span class="elsevierStyleHsp" style=""></span>h.</p><p id="par0130" class="elsevierStylePara elsevierViewall">Unlike ASA grade, the associated comorbidities reflected the health condition of patients. Among antiaggregation patients, 60% presented 3 or more associated comorbidities, compared to 42.1% in non antiaggregation subjects, and the mean number of associated comorbidities was higher among antiaggregation patients than among non antiaggregation patients. There was an association between the number of comorbidities and mortality at 12 months after the surgery, but not with the fact of presenting 3 or more associated comorbidities, as opposed to the report of Roche et al.,<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">19</span></a> whose study noted that the presence of 3 or more comorbidities significantly increased mortality after 1 month among elderly patients.</p><p id="par0135" class="elsevierStylePara elsevierViewall">The literature describes the determination of perioperative bleeding through formulas based on pre- and postoperative hematocrit and volemia. Mas-Atance et al.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">9</span></a> reported similar perioperative bleeding levels between non anti-platelet patients suffering proximal femoral fracture, anti-platelet patients intervened before 48<span class="elsevierStyleHsp" style=""></span>h and anti-platelet patients intervened after the fifth day of admission. Our study presents limitations to determine perioperative bleeding, since the result of surgical drainages removed after 48<span class="elsevierStyleHsp" style=""></span>h and preoperative hematocrit were not registered in a high percentage of cases. As indirect data, we did register the need for transfusion and the number of packed red blood cells transfused, which were similar in both groups.</p><p id="par0140" class="elsevierStylePara elsevierViewall">The majority of anesthesiologists prefer to use spinal anesthesia, as long as it is not contraindicated, even though there is not enough scientific evidence regarding which anesthetic technique provides the best results in patients with hip fractures.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">3,20,21</span></a> In a study of 30 patients with proximal femoral fracture and anti-aggregant treatment with clopidogrel, Maheshwari et al.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">8</span></a> indicated that spinal anesthesia was a predictor of mortality at 12 months after the surgery in a univariate regression study. Mas-Atance et al.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">9</span></a> reported that general anesthesia was the norm among antiaggregation patients with proximal femoral fracture intervened before 48<span class="elsevierStyleHsp" style=""></span>h; however, in cases where the surgery was delayed due to the anti-aggregant treatment, anesthesiologists clearly opted for locoregional procedures. In our series, all antiaggregation patients had a delay over 3 days and the anesthesiologist indicated spinal anesthesia in all cases.</p><p id="par0145" class="elsevierStylePara elsevierViewall">Postoperative complications were similar in both groups (22% among antiaggregation patients and 15.6% in non antiaggregation patients), with no influence of ASA grade. In their series of antiaggregation patients treated with clopidogrel, Maheshwari et al.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">8</span></a> reported a rate of 43%, whilst Hossain et al.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">22</span></a> reported 8% in 50 patients with displaced subcapital femoral fracture treated through partial prosthesis in whom clopidogrel treatment was not interrupted.</p><p id="par0150" class="elsevierStylePara elsevierViewall">The effect of treatment with ASA on the time of surgical intervention in patients with hip fracture did not increase intraoperative bleeding or the risk of subdural hematoma in cases with spinal anesthesia.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">3,23</span></a> Moreover, it should only be interrupted if the risk of hemorrhage was greater than the cardiovascular risk.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">24</span></a> For this reason, delaying surgery due to anti-aggregant treatment is not justified in patients treated with ASA. In our series, the mean surgical delay was similar between patients with no anti-platelets and anti-platelet patients treated with ASA. However, the percentage of patients with ASA grade III/IV was higher, which could justify the greater mortality observed at 12 months after the surgery.</p><p id="par0155" class="elsevierStylePara elsevierViewall">Regarding the management of clopidogrel, there is a lack of consensus among patients with hip fracture.<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">25–27</span></a> The Clinical Practice Guideline on the perioperative management of anti-platelet drugs in non-cardiac surgery published by SEDAR<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">4</span></a> recommends interrupting treatment with clopidogrel between 3 and 7 days before an invasive procedure, although it indicates that recovery of hemostatic competence probably does not require a total elimination of the drug and that there is great variability between individuals regarding the grade of platelet inhibition. Hossain et al<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">22</span></a> compared postoperative complications between 50 patients with displaced subcapital femoral fractures treated with partial prostheses in whom treatment with clopidogrel was not interrupted and 52 non anti-aggregation patients with the same type of fracture and treatment, and found no differences between both groups, although 88% of patients treated with clopidogrel required general anesthesia. In our series, taking into account the limitations of being a reduced group of cases to extract conclusions, these patients had a higher number of comorbidities, ASA grade and longer surgical delay, which could explain the fact that they presented the highest mortality at 12 months after the surgery out of the 3 groups.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Conclusions</span><p id="par0160" class="elsevierStylePara elsevierViewall">In our series, patients with anti-platelet treatment were older and presented a higher preoperative number of comorbidities, mainly cardiac, and ASA grade. Antiaggregation conditioned an extension in surgical delay and hospital admission. Taking into account the limitations of the present study, patients treated with anti-platelet drugs presented greater cumulative mortality at 12 months after surgery than cases with no anti-platelet treatment, with no increase in surgical and medical complications or in transfusion requirements being observed.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Level of evidence</span><p id="par0165" class="elsevierStylePara elsevierViewall">Level of evidence III.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Ethical responsibilities</span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Protection of people and animals</span><p id="par0170" class="elsevierStylePara elsevierViewall">The authors declare that this investigation did not require experiments on humans or animals.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Confidentiality of data</span><p id="par0175" class="elsevierStylePara elsevierViewall">The authors declare that this work does not reflect any patient data.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Right to privacy and informed consent</span><p id="par0180" class="elsevierStylePara elsevierViewall">The authors declare that this work does not reflect any patient data.</p></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Financing</span><p id="par0185" class="elsevierStylePara elsevierViewall">The authors declare that they have not received any financing to conduct the present study.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Conflict of interests</span><p id="par0190" class="elsevierStylePara elsevierViewall">The authors have no conflict of interests to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:14 [ 0 => array:3 [ "identificador" => "xres436185" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec459507" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres436184" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Material y método" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec459506" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Material and method" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Statistical analysis" ] ] ] 6 => array:2 [ "identificador" => "sec0020" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0025" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0030" "titulo" => "Conclusions" ] 9 => array:2 [ "identificador" => "sec0035" "titulo" => "Level of evidence" ] 10 => array:3 [ "identificador" => "sec0040" "titulo" => "Ethical responsibilities" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0045" "titulo" => "Protection of people and animals" ] 1 => array:2 [ "identificador" => "sec0050" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0055" "titulo" => "Right to privacy and informed consent" ] ] ] 11 => array:2 [ "identificador" => "sec0060" "titulo" => "Financing" ] 12 => array:2 [ "identificador" => "sec0065" "titulo" => "Conflict of interests" ] 13 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2014-05-12" "fechaAceptado" => "2014-07-16" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec459507" "palabras" => array:5 [ 0 => "Hip fracture" 1 => "Antiplatelet agents" 2 => "Hip prostheses" 3 => "Complications" 4 => "Mortality" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec459506" "palabras" => array:5 [ 0 => "Fractura de cadera" 1 => "Inhibidores de la agregación plaquetaria" 2 => "Prótesis de cadera" 3 => "Complicaciones" 4 => "Mortalidad" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">To assess complications and factors predicting one-year mortality in patients on anti-platelet agents presenting with femoral neck fractures undergoing hip hemiarthroplasty surgery.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Material and methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A review was made on 50 patients on preoperative anti-platelet agents and 83 patients without preoperative anti-platelet agents. Patients in both groups were treated with cemented hip hemiarthroplasty. A statistical comparison was performed using epidemiological data, comorbidities, mental state, complications and mortality. There was no lost to follow-up.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The one-year mortality was 20.3%. In patients without preoperative anti-platelet agents it was 14.4% and in patients with preoperative anti-platelet agents was 30%. Age, ASA grade, number of comorbidities and anti-platelet agent therapy were predictors of one-year mortality.</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The one-year mortality of patients on clopidogrel was 46.1%, versus 24.3% in patients on acetylsalicylic acid.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusion</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Patients with preoperative anti-platelet therapy were older and had greater number of comorbidities, ASA grade, delayed surgery, and a longer length of stay than patients without anti-platelet therapy. The one-year mortality was higher in patients with preoperative anti-platelet therapy.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusion" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivo</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Evaluar las complicaciones y la mortalidad en pacientes antiagregados con fractura cervical desplazada de cadera tratada con prótesis parcial.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Material y método</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Estudio de 133 pacientes en el período 2008 a 2010 que se distribuyeron en 2 grupos, con tratamiento antiagregante en el momento del ingreso (50 pacientes) y sin tratamiento antiagregante (83 pacientes). Todos tratados mediante sustitución parcial de cadera con implante de prótesis parcial modular cementada. Se valoraron los datos epidemiológicos, comorbilidades, estado mental, complicaciones y mortalidad. No hubo pérdidas de seguimiento.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">La mortalidad anual de la serie completa fue del 20,3%; en pacientes no antiagregados, del 14,4%, y en pacientes antiagregados, del 30%. Los predictores de mortalidad a los 12<span class="elsevierStyleHsp" style=""></span>meses fueron la edad, el grado ASA, el número de comorbilidades asociadas y la antiagregación.</p><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Los pacientes antiagregados con clopidogrel tuvieron una mortalidad del 46,1%, frente al 24,3% de los pacientes antiagregados con ácido acetilsalicílico.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Los pacientes antiagregados tenían mayor edad, número de comorbilidades, grado ASA, demora quirúrgica y estancia hospitalaria que los no antiagregados. A los 12<span class="elsevierStyleHsp" style=""></span>meses de la cirugía la mortalidad acumulada ha sido mayor en pacientes antiagregados que en los no antiagregados.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Material y método" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Agudo Quiles M, Sanz-Reig J, Alcalá-Santaella Oria de Rueca R. Antiagregación en pacientes con fractura subcapital desplazada de fémur tratados con prótesis parcial cementada. Estudio de complicaciones y mortalidad. Rev Esp Cir Ortop Traumatol. 2015;59:104–111.</p>" ] ] "multimedia" => array:4 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1140 "Ancho" => 1617 "Tamanyo" => 88032 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Cumulative mortality in the 3 groups.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">AHT: arterial hypertension; ASA grade: grade according to the American Society of Anesthesiologists classification; CVA: cerebrovascular accident.</p><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Quantitative variables are shown as mean (range)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Anti-aggregation \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Non anti-aggregation \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">N \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">83 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Age, years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">84.1 (68–96)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">81.4 (65–97)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>7.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.03 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Female/male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">37/13 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">62/21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.73 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Right/left \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">26/24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">44/39 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.52 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">AHT (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">39/10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">47/36 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.01 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Cardiac pathology (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">27/23 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">17/66 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Pulmonary pathology (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7/43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">11/72 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.54 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">CVA (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10/39 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6/77 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.02 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Parkinson (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2/48 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8/75 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.20 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Diabetes (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12/38 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">23/60 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.42 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Dementia (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12/38 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">27/56 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.21 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Number of comorbidities \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.0 (2–7)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.8 (0–6)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.03 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Comorbidity (0–2/>3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20/30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">48/35 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.01 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">ASA grade (I–II/III–IV) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10/40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">60/23 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab680811.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Preoperative data, both groups.</p>" ] ] 2 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Anti-aggregation \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Non anti-aggregation \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Mortality at 3 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4/50 (8%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5/83 (6%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.45 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Mortality at 6 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7/50 (14%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8/83 (9.6%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.30 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Mortality at 1 year \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15/50 (30%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12/83 (14.4%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.02 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab680810.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Cumulative mortality, both groups.</p>" ] ] 3 => array:7 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">ASA: acetylsalicylic acid; ASA grade: grade according to the American Society of Anesthesiologists classification; Hb: hemoglobin.</p><p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">Quantitative variables are shown as mean (range)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation. Mortality is indicated as cumulative.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">ASA \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clopidogrel \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">N \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">37 patients: 300<span class="elsevierStyleHsp" style=""></span>mg (19)/100<span class="elsevierStyleHsp" style=""></span>mg (18) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13 patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Age, years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">84.4 (72–96)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>5.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">83.1 (68–95)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>9.1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.86 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Female/Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">27/10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10/3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.57 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Right/Left \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">21/16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8/5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.57 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Surgical delay \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.2 3(3–11)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6.8 (4–18)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.01 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Hospital stay \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8.1 (3–19)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.2 (6–23)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.003 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Preoperative Hb \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12.9 (9.3–17.2)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12.8 (8.5–15.7)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.82 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Postoperative Hb \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10.9 (6.5–14.1)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10.1 (8.1–12.7)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.15 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Number of comorbidities \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.1 (2–7)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.5 (2–6)<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.39 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Comorbidity (0–2/>3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">16/21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4/9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.32 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">ASA grade (I–II/III–IV) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8/29 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2/11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.47 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Transfusion (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4/33 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3/10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.35 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Complications (Yes/No) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0/37 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2/11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.05 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Mortality at 3 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2/37 (5.4%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2/13 (15.3%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.27 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Mortality 6 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3/37 (8.1%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4/13 (30.7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.06 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Mortality at 1 year \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9/37 (24.3%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6/13 (46.1%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.17 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab680812.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Data from patients treated with anti-platelet drugs.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:27 [ 0 => array:3 [ "identificador" => "bib0140" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "G.H. Guyatt" 1 => "E.A. Akl" 2 => "M. Crowther" 3 => "D.D. Gutterman" 4 => "H.J. Schünemann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.1412S3" "Revista" => array:7 [ "tituloSerie" => "Chest" "fecha" => "2012" "volumen" => "141" "numero" => "2 Suppl." "paginaInicial" => "7S" "paginaFinal" => "47S" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22315257" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0145" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemiartroplastia cementada tras fractura subcapital de fémur: análisis de supervivencia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.A. Ruiz-Ibán" 1 => "P. Crespo-Hernández" 2 => "S. Fernández-Roldán" 3 => "J. Días-Heredia" 4 => "P. Martínez-Ureña" 5 => "A. Muriel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Esp Cir Ortop Traumatol" "fecha" => "2008" "volumen" => "52" "paginaInicial" => "206" "paginaFinal" => "212" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0150" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anciano afecto de fractura de cadera: guía de buena práctica clínica en geriatría" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Sociedad Española de Geriatría y Gerontología, Sociedad Española de Cirugía Ortopédica y Traumatología" "etal" => false "autores" => array:3 [ 0 => "J.A. Avellana Zaragoza" 1 => "L. Ferrández Portal" 2 => "A. Areosa Sastre" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2007" "editorial" => "Elsevier, Sociedad Española de Geriatría y Gerontología" "editorialLocalizacion" => "Madrid" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0155" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guía de práctica clínica sobre el manejo perioperatorio de antiagregantes plaquetarios en cirugía no cardiaca (Sociedad Española de Anestesiología y Reanimación)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Sierra" 1 => "A. Gómez-Luque" 2 => "J. Castillo" 3 => "J.V. Llau" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Anestesiol Reanim" "fecha" => "2011" "volumen" => "58" "numero" => "Suppl. 1" "paginaInicial" => "S1" "paginaFinal" => "S16" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0160" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "American Society of Anesthesiologists. Relative value guide 2014. Available at: <a href="https://ecommerce.asahq.org/p-668-2014-relative-value-guidesupregsup-a-guide-for-anesthesia-values-book.aspx">https://ecommerce.asahq.org/p-668-2014-relative-value-guidesupregsup-a-guide-for-anesthesia-values-book.aspx</a> [accessed 09.05.14]." ] ] ] 5 => array:3 [ "identificador" => "bib0165" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of a mental test score for assessment of mental impairment in the elderly" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H.M. Hodkinson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Age Ageing" "fecha" => "1972" "volumen" => "4" "paginaInicial" => "233" "paginaFinal" => "238" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0170" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hip fractures in the elderly: predictors of one year mortality" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "G.B. Aharonoff" 1 => "K.J. Koval" 2 => "M.L. Skovron" 3 => "J.D. Zuckerman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Orthop Trauma" "fecha" => "1997" "volumen" => "11" "paginaInicial" => "162" "paginaFinal" => "165" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9181497" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0175" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Factors influencing mortality in patients on antiplatelet agents presenting with proximal femoral fractures" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Maheshwari" 1 => "M. Acharya" 2 => "M. Monda" 3 => "R. Pandey" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Orthop Surg" "fecha" => "2011" "volumen" => "19" "paginaInicial" => "314" "paginaFinal" => "316" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0180" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estudio comparativo aleatorizado de la intervención quirúrgica temprana frente a la demorada en los pacientes con fractura de cadera tratados con antiagregantes plaquetarios. Determinación de la agregabilidad plaquetaria y el sangrado perioperatorio, y la revisión de la mortalidad al año" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Mas-Atance" 1 => "C. Marzo-Alonso" 2 => "M. Matute-Crespo" 3 => "J.J. Trujillano-Cabello" 4 => "N. Català-Tello" 5 => "M. De Miguel-Artalf" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.recot.2011.12.007" "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cir Ortop Traumatol" "fecha" => "2013" "volumen" => "57" "paginaInicial" => "240" "paginaFinal" => "253" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23885649" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0185" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "F. Hu" 1 => "C. Jiang" 2 => "J. Shen" 3 => "P. Tang" 4 => "Y. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.injury.2011.05.017" "Revista" => array:6 [ "tituloSerie" => "Injury" "fecha" => "2012" "volumen" => "43" "paginaInicial" => "676" "paginaFinal" => "680" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21683355" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0190" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fracturas de cadera en ancianos: predictores de mortalidad al año en pacientes operados" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "F.E. Navarrete" 1 => "F. Baixauli" 2 => "B. Fenollosa" 3 => "T. Jolín" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Esp Cir OrtopTtraumatol" "fecha" => "2009" "volumen" => "53" "paginaInicial" => "237" "paginaFinal" => "241" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0195" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postoperative mortality and factors related to mortality after bipolar hemiarthroplasty in patients with femoral neck fractures" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Y.W. Lim" 1 => "S.Y. Kwon" 2 => "S.K. Han" 3 => "D.H. Sun" 4 => "S.P. Choi" 5 => "Y.S. Kim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arth.2009.06.019" "Revista" => array:6 [ "tituloSerie" => "J Arthroplasty" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "1277" "paginaFinal" => "1280" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19643565" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0200" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of hip fracture in older people: A national clinical guideline" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Scottish Intercollegiate Guidelines Network (SIGN)" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2009" "editorial" => "SIGN" "editorialLocalizacion" => "Edinburgh" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://ecommerce.asahq.org/p-668-2014-relative-value-guidesupregsup-a-guide-for-anesthesia-values-book.aspx" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0205" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S.K. Khan" 1 => "S. Karla" 2 => "A. Khanna" 3 => "M.M. Thiruvengada" 4 => "M.J. Parker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.injury.2009.01.010" "Revista" => array:6 [ "tituloSerie" => "Injury" "fecha" => "2009" "volumen" => "40" "paginaInicial" => "692" "paginaFinal" => "697" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19450802" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0210" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early mortality after hip fracture: is delay before surgery important?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.G. Moran" 1 => "R.T. Wenn" 2 => "M. Sikand" 3 => "A.M. Taylor" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bone Joint Surg (Am)" "fecha" => "2005" "volumen" => "87-A" "paginaInicial" => "483" "paginaFinal" => "489" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0215" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Length of stay, mortality, morbidity and delay to surgery in hip fractures" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "K.A. Lefaivre" 1 => "S.A. Macadam" 2 => "D.J. Davidson" 3 => "R. Gandhi" 4 => "H. Chan" 5 => "H.M. Broekhuyse" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bone Joint Surg (Br)" "fecha" => "2009" "volumen" => "91-B" "paginaInicial" => "922" "paginaFinal" => "927" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0220" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early mortality after surgical fixation of hip fractures in the elderly: an analysis of data from the Scottish Hip Fracture Audit" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "G. Holt" 1 => "R. Smith" 2 => "K. Duncan" 3 => "D.F. Finlayson" 4 => "A. Gregori" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bone Joint Surg (Br)" "fecha" => "2008" "volumen" => "90B" "paginaInicial" => "1357" "paginaFinal" => "1363" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0225" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mortality risk after hip fracture" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Richmond" 1 => "G.B. Aharonoff" 2 => "J.D. Zuckerman" 3 => "K.J. Koval" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Orthop Trauma" "fecha" => "2003" "volumen" => "17" "paginaInicial" => "53" "paginaFinal" => "56" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12499968" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0230" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.J. Roche" 1 => "R.T. Wenn" 2 => "O. Sahota" 3 => "C.G. Moran" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.38643.663843.55" "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2005" "volumen" => "331" "paginaInicial" => "1374" "paginaFinal" => "1376" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16299013" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0235" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tratamiento multidisciplinar de la fractura de cadera" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "Grupo de Estudio e Investigación de la Osteoporosis SECOT" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2009" "editorial" => "Multimédica Proyectos" "editorialLocalizacion" => "Madrid" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0240" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.J. Luger" 1 => "C. Kammerlander" 2 => "M. Gosch" 3 => "M.F. Luger" 4 => "U. Kammerlander-Knauer" 5 => "T. Roth" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-010-1399-7" "Revista" => array:7 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2010" "volumen" => "21" "numero" => "Suppl. 4" "paginaInicial" => "S555" "paginaFinal" => "S572" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21057995" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0245" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "F.S. Hossain" 1 => "R. Rambani" 2 => "H. Ribee" 3 => "L. Koch" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Orthopaed Traumatol" "fecha" => "2013" "volumen" => "14" "paginaInicial" => "171" "paginaFinal" => "177" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0250" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The association between aspirin and blood loss in hip fracture patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.T. Kennedy" 1 => "S. Roche" 2 => "S.M. Fleming" 3 => "B. Lenehan" 4 => "W. Curtin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Orthop Belg" "fecha" => "2006" "volumen" => "72" "paginaInicial" => "29" "paginaFinal" => "33" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16570891" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0255" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation. Review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "W. Burger" 1 => "J.M. Chemnitius" 2 => "G.D. Kneissl" 3 => "G. Rucker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2796.2005.01477.x" "Revista" => array:6 [ "tituloSerie" => "J Intern Med" "fecha" => "2005" "volumen" => "257" "paginaInicial" => "399" "paginaFinal" => "414" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15836656" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0260" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Operative delay for orthopedic patients on clopidogrel (Plavix): a complete lack of consensus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "W.F. Lavelle" 1 => "E.A. Demers Lavelle" 2 => "R. Uhl" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/TA.0b013e3180485d23" "Revista" => array:6 [ "tituloSerie" => "J Trauma" "fecha" => "2008" "volumen" => "64" "paginaInicial" => "996" "paginaFinal" => "1000" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18404067" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0265" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Perioperative management of trauma patients admitted on clopidogrel (Plavix). A survey of orthopaedic departments across the United Kingdom" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.S. Inman" 1 => "Y. Michla" 2 => "P.F. Partington" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.injury.2007.01.011" "Revista" => array:6 [ "tituloSerie" => "Injury" "fecha" => "2007" "volumen" => "38" "paginaInicial" => "625" "paginaFinal" => "630" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17472797" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0270" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Is clopidogrel stopped prior to hip fracture surgery—a survey of current practice in the United Kingdom" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Palan" 1 => "A. Odutola" 2 => "S.P. White" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.injury.2007.05.014" "Revista" => array:6 [ "tituloSerie" => "Injury" "fecha" => "2007" "volumen" => "38" "paginaInicial" => "1279" "paginaFinal" => "1285" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17880978" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/19888856/0000005900000002/v2_201502210342/S1988885615000073/v2_201502210342/en/main.assets" "Apartado" => array:4 [ "identificador" => "7577" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/19888856/0000005900000002/v2_201502210342/S1988885615000073/v2_201502210342/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1988885615000073?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 0 | 4 |
2024 October | 14 | 3 | 17 |
2024 September | 33 | 6 | 39 |
2024 August | 22 | 7 | 29 |
2024 July | 14 | 7 | 21 |
2024 June | 24 | 3 | 27 |
2024 May | 31 | 1 | 32 |
2024 April | 23 | 4 | 27 |
2024 March | 30 | 3 | 33 |
2024 February | 24 | 6 | 30 |
2024 January | 22 | 8 | 30 |
2023 December | 23 | 8 | 31 |
2023 November | 12 | 3 | 15 |
2023 October | 28 | 17 | 45 |
2023 September | 16 | 2 | 18 |
2023 August | 16 | 10 | 26 |
2023 July | 14 | 10 | 24 |
2023 June | 18 | 3 | 21 |
2023 May | 30 | 10 | 40 |
2023 April | 38 | 7 | 45 |
2023 March | 21 | 7 | 28 |
2023 February | 20 | 8 | 28 |
2023 January | 23 | 8 | 31 |
2022 December | 11 | 8 | 19 |
2022 November | 22 | 11 | 33 |
2022 October | 16 | 11 | 27 |
2022 September | 16 | 17 | 33 |
2022 August | 14 | 12 | 26 |
2022 July | 15 | 15 | 30 |
2022 June | 18 | 14 | 32 |
2022 May | 28 | 8 | 36 |
2022 April | 15 | 14 | 29 |
2022 March | 23 | 9 | 32 |
2022 February | 27 | 7 | 34 |
2022 January | 39 | 4 | 43 |
2021 December | 25 | 11 | 36 |
2021 November | 24 | 8 | 32 |
2021 October | 53 | 15 | 68 |
2021 September | 37 | 12 | 49 |
2021 August | 49 | 7 | 56 |
2021 July | 23 | 7 | 30 |
2021 June | 15 | 9 | 24 |
2021 May | 15 | 6 | 21 |
2021 April | 26 | 21 | 47 |
2021 March | 18 | 16 | 34 |
2021 February | 14 | 6 | 20 |
2021 January | 9 | 4 | 13 |
2020 December | 1 | 0 | 1 |
2019 November | 2 | 2 | 4 |
2018 April | 1 | 0 | 1 |
2018 February | 3 | 1 | 4 |
2018 January | 2 | 1 | 3 |
2017 December | 4 | 2 | 6 |
2017 November | 8 | 2 | 10 |
2017 October | 10 | 4 | 14 |
2017 September | 9 | 4 | 13 |
2017 August | 9 | 5 | 14 |
2017 July | 8 | 4 | 12 |
2017 June | 11 | 3 | 14 |
2017 May | 5 | 8 | 13 |
2017 April | 15 | 3 | 18 |
2017 March | 13 | 17 | 30 |
2016 October | 0 | 6 | 6 |
2016 September | 0 | 2 | 2 |
2016 August | 0 | 4 | 4 |
2016 July | 0 | 1 | 1 |
2016 June | 0 | 12 | 12 |
2016 February | 0 | 3 | 3 |
2015 December | 0 | 2 | 2 |
2015 September | 0 | 1 | 1 |
2015 August | 1 | 1 | 2 |
2015 July | 0 | 1 | 1 |
2015 April | 1 | 2 | 3 |
2015 March | 1 | 4 | 5 |